2’-Deoxy-N3-methylcytidine hydriodide

• CAT Number: I040901
• CAS Number: 79043-77-9
• Molecular Formula: C10H16IN3O4
• Molecular Weight: 369.16
• Purity: ≥95%
• Synonyms: 1-[(2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one;hydroiodide
• IUPAC Name: 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one;hydroiodide
• InChI: InChI=1S/C10H15N3O4.HI/c1-12-8(11)2-3-13(10(12)16)9-4-6(15)7(5-14)17-9;/h2-3,6-7,9,11,14-15H,4-5H2,1H3;1H/t6-,7-,9-;/m1./s1
• InChIKey: DFGPJCYBYINQQK-JJVRHELESA-N
• SMILES: CN1C(=N)C=CN(C1=O)C2CC(C(O2)CO)O.I

2′-Deoxy-N3-methylcytidine hydriodide(CAT: I040901) is a purine nucleoside analog with potent antitumor activity, particularly effective against indolent lymphoid malignancies. This compound interferes with DNA synthesis by incorporating into the DNA strand, leading to chain termination and inhibition of replication. Additionally, it induces apoptosis in cancer cells through mechanisms such as the activation of cell death pathways. Due to its ability to target and disrupt the proliferation of malignant cells, 2′-Deoxy-N3-methylcytidine hydriodide can be used in Cancer Disease Research, offering a potential therapeutic approach for treating specific types of lymphoid cancers.